Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesalazine enemas and mucosal gut flora in inflammatory bowel disease
2006-004162-13Phase 2Terminated
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in autoimmune colitis and Crohn's disease comparing Mesalazine enema with Placebo enema (2 arms). Primary endpoint: Percentage decrease in the number of germs/ml mucus at week 4 (LOCF). Started Oct 2006; status: terminated.
02
Drugs
Salcrozine
03
Conditions
autoimmune colitisCrohn's disease
Beyond the preview
Go deeper on 2006-004162-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004162-13.